Socionext, page-50

correct. Considering a lot of employees are ex ARM I would assume they are taking on almost their exact model.

yes akida will need to be implemented into 100s of millions of devices to become significantly profitable… the benifit of BRN is that it is so versatile. It has the potential to be in billions of devices in the future. The potential is enormous but they have to get there first.

I don’t think they will but if renesas make 100 million “neuromorphic chips” per year then BRN stands to make 10 million a year from them in royalties… and they don’t have to do anything for it. Now multiply that out across 10 renesas size licenses and you’ll see significant revenue and BRN will be extremely profitable.

then again renesas may only make 10 million “neuromorphic chips” a year and you’ll need 100 contracts to make significant revenue to justify a $1-10 billion dolllar company